Showing results (131-140 of 302) with videos related to
Sort By:
Pageof 31
Clinical & Developmental Immunology|May 24, 2011
Anti-IL-6 receptor antibody causes less promotion of tuberculosis infection than anti-TNF-α antibody in miceMasaji Okada, Yoko Kita, Noriko Kanamaru, et al.Journal of Thoracic Disease|September 18, 2020
Seroradiologic prognostic evaluation of acute exacerbation in patients with idiopathic interstitial pneumonia: a retrospective observational studyToru Arai, Masanori Akira, Chikatoshi Sugimoto, et al.Respirology (Carlton, Vic.)|December 21, 2016
Nintedanib in Japanese patients with idiopathic pulmonary fibrosis: A subgroup analysis of the INPULSIS® randomized trialsArata Azuma, Hiroyuki Taniguchi, Yoshikazu Inoue, et al.Plos One|March 1, 2019
Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosisMasaki Hirose, Akiko Matsumuro, Toru Arai, et al.Respirology (Carlton, Vic.)|September 18, 2012
Cytomegalovirus infection during immunosuppressive therapy for diffuse parenchymal lung diseaseToru Arai, Yoshikazu Inoue, Kazunobu Tachibana, et al.Orphanet Journal of Rare Diseases|September 30, 2020
Clinical significance of serum anti-granulocyte-macrophage colony-stimulating factor autoantibodies in patients with sarcoidosis and hypersensitivity pneumonitisKanako Katayama, Masaki Hirose, Toru Arai, et al.Journal of Palliative Medicine|August 22, 2018
Morphine for Refractory Dyspnea in Interstitial Lung Disease: A Phase I Study (JORTC-PAL 05)Yoshinobu Matsuda, Tatsuya Morita, Tempei Miyaji, et al.Respirology (Carlton, Vic.)|May 17, 2017
High-dose prednisolone after intravenous methylprednisolone improves prognosis of acute exacerbation in idiopathic interstitial pneumoniasToru Arai, Kazunobu Tachibana, Chikatoshi Sugimoto, et al.Respiratory Investigation|November 6, 2023
Japanese clinical practice guide 2022 for hypersensitivity pneumonitisHiromi Tomioka, Yasunari Miyazaki, Yoshikazu Inoue, et al.Respirology (Carlton, Vic.)|November 21, 2013
CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosisToru Arai, Yoshikazu Inoue, Chikatoshi Sugimoto, et al.Pageof 31